A review of the GUARDIAN trial results: Clinical implications and the significance of elevated perioperative CK-MB on 6-month survival

Journal of Cardiac Surgery

Volumn 18, Issue SUPPL. 1, 2003, Pages 13-20

  Chaitman, Bernard R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARIPORIDE; CREATINE KINASE MB; PLACEBO; SODIUM PROTON EXCHANGE PROTEIN;

ADULT; AGED; BLEEDING; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; KIDNEY FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERIOPERATIVE PERIOD; PROGNOSIS; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; STROKE; SURVIVAL;

ANTI-ARRHYTHMIA AGENTS; CREATINE KINASE; CREATINE KINASE, MB FORM; GUANIDINES; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SODIUM-HYDROGEN ANTIPORTER; SULFONES; SURVIVAL RATE;

EID: 0037242672     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8191.18.s1.3.x     Document Type: Conference Paper

References (30)

1. American Heart Association. 2002 heart and stroke statistical update. [American Heart Association Web site]. http://216.185.112.5/downloadable/heart/10148328094661013190990123HS_State_ 02.pdf. Accessed: July 12, 2002.
2. White HD. Unmet therapeutic needs in the management of acute ischemia. Am J Cardiol 1997;80:2B-10B.
3. Fliegel L, Wang H. Regulation of the Na+/H+ exchanger in the mammalian myocardium. J Mol Cell Cardiol 1997;29:1991-1999.
4. + exchangers of mammalian cells. J Biol Chem 1997;272:22373-22376.
5. Frölich O, Karmazyn M. The Na-H exchanger revisited: An update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res 1997;36:138-148.
6. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol 1999;83:10G-18G.
7. Klein HH, Pich S, Bohle RM, et al. Myocardial protection by Na(+)-H+ exchange inhibition in ischemic, reperfused porcine hearts. Circulation 1995;92:912-917.
8. Theroux P, Chaitman BR, Danchin N, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: Main results of the GUARDIAN trial. Circulation 2000;102:3032-3038.
9. Klatte K, Chaitman BR, Theroux P, et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: Results from the GUARDIAN trial. J Am Coll Cardiol 2001;38:1070-1077.
10. El-shafei A, Klatte K, Gavard J. The clinical significance of minimal enzyme 'leaks' after percutaneous coronary intervention [abstract]. Circulation 2000;102:II-752.
11. Sakai S, Chaitman BR, Gavard JA, et al. Increasing the pre-test likelihood estimate for non ST-elevation myocardial infarction in acute coronary syndrome: Results from the GUARDIAN trial [abstract]. Circulation 2001;104(suppl):II-649.
12. Gavard JA, Chaitman BR, Sakai S, et al. Does elevated CK-MB after coronary bypass surgery have the same prognostic: significance as after an acute coronary syndrome [abstract]? Circulation 2001;104(suppl):II-597.
13. Sakai S, Chaitman BR, Gavard JA, et al. Predicting six month mortality in acute coronary syndromes: Results from the GUARDIAN trial. Circulation 2001;104(suppl):II-697.
14. Boyce SW, Bartels C, Bolli R. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients. Results of the CABG surgery cohort of the GUARDIAN study. Circulation 2001;104(suppl):II-687.
15. Chaitman BR, Sakai S, Hasan F, et al. Do all Q waves after coronary bypass surgery impact 6-month prognosis? [abstract]. J Am Coll Cardiol 2002;39 (suppl. A):335A.
16. Theroux P, Chaitman BR, Erhardt L, et al. Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: The Guard During Ischemia Against Necrosis (GUARDIAN) trial. Curr Control Trials Cardiovasc Med 2000;1:59-67.
17. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486-502.
18. Chaitman BR, Zhou SH, Tamesis B, et al. Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI). J Electrocardiol 1996;29:265-277.
19. Cohen M, Stinnett SS, Weatherley BD, et al. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy. Am Heart J 2000;139:962-970.
20. 2+ overload in isolated perfused rabbit heart. Circulation 1994;89:2787-2798.
21. + exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow. Circulation 2000;102:1977-1982.
22. +-overload in ischemia and is cardioprotective. J Mol Cell Cardiol 1999;31:1985-1995.
23. 2+ overload and prolonged acidosis on reperfusion. Circulation 2000;101:2749-2755.
24. Yasutake M, Ibuki C, Hearse DJ, et al. Na+/H+ exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol 1994;267:H2430-H2440.
25. Costa MA, Carere RG, Lichtenstein SV, et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001;104:2689-2693.
26. Singh S, Sykora K, Tu JV, et al. Late follow-up of the Warm Heart Trial: Eight year results. J Am Coll Cardiol 2002;39 (suppl. A):320A.
27. Steuer J, Horte LG, Lindahl B, et al. Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting. Eur Heart J 2002;23:1219-1227.
28. Tleyjeh I, Ziada KM, Almahameed A, et al. Perioperative creatine kinase elevation is a strong predictor of early and late mortality after coronary bypass grafting [abstract]. J Am Coll Cardiol 2002;39(suppl. A):436A.
29. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-2130.
30. Weber W, Harnisch L, Jessel A. Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft (CABG) surgery. Clin Pharmacol Ther 2002;71:457-467.